of the Federal Food, Drug, and Cosmetic Act (FDCA).* Industry Update: Interim 503A and 503B Bulks Lists New Revisions Not all medical oversight is the same and wording matters., Terms like medical oversight and compounded are often used loosely, but true medical care involves licensed providers, proper FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved